Efficacy of Anlotinib combined with S-1 as the second-line treatment for advanced soft tissue sarcoma

Xiaojing Tie, Peijie Liu(Beijing University of Posts and Telecommunications), Chenguang Yang(University of Liverpool), Yao-Hong Gao(Xian Central Hospital)
Asian Journal of Surgery
August 14, 2022
Cited by 0


Related Papers